# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-22-008495
Filing Date
2022-05-16
Accepted
2022-05-16 09:31:45
Documents
8
Period of Report
2022-05-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | dp173094_6k.htm | 6-K | 11191
2 | EXHIBIT 99.1 | dp173094_ex9901.htm | EX-99.1 | 87511
3 | FORM EX-99.2 | dp173094_ex9902.htm | EX-99.2 | 2158
4 | GRAPHIC | image_001.jpg | GRAPHIC | 3738
5 | GRAPHIC | image_002.jpg | GRAPHIC | 126640
6 | GRAPHIC | image_003.jpg | GRAPHIC | 218734
7 | GRAPHIC | image_004.jpg | GRAPHIC | 77897
8 | GRAPHIC | image_005.jpg | GRAPHIC | 207468
| Complete submission text file | 0000950103-22-008495.txt |  | 976258

Mailing Address RUE DU CENTRE 172, CH-1025 SAINT-SULPICE V8 00000
Business Address RUE DU CENTRE 172, CH-1025 SAINT-SULPICE V8 00000 41 21 694 10 60
SOPHiA GENETICS SA (Filer) CIK: 0001840706 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40627 | Film No.: 22926030
SIC: 2836 Biological Products, (No Diagnostic Substances)